BSECompany Update2 Nov 2026 · 2 Nov 2026, 05:31 pm
PFA
Shree Ganesh Biotech (India) Ltd · 539470
✦ AI SummaryResults
Shree Ganesh Biotech (India) Ltd has informed BSE that it does not have any unutilized funds from public issues, rights issues, or QIPs as of 30th September 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
Attachments (1)
📄pdf
Download →
8ee61520-7a82-4abf-aed4-7c9c70173023.pdf
View document text
SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED
CIN: L70101WB1982PLC121196
Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR, KAMDHENU BUILDING, KOLKATA -700016
Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.bar
Date: 02.11.2026
To, To, To,
Listing Department, The Secretary, Head - Listing
BSE Limited, The Calcutta Stock Metropolitan Stock Exchange
P J Tower, Dalal Exchange Ltd, of India Limited
Street 7, Lyons Range, Vibgyor Towers, 4th floor, Plot
Mumbai-400001 Kolkata - 700001 No C 62, Opp. Trident Hotel
Bandra Kurla Complex, Bandra
(E),
Mumbai – 400098
Scrip Code: 539470 Scrip Code: 29221 Scrip Code: SHREEGANES
Dear Sir/Madam,
Sub: Disclosure under Regulation 32(1) of SEBI (listing Obligation and Disclosure Requirements)
Regulations, 2015
Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding
statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue,
Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation
and Disclosure Requirements) Regulations, 2015, we would like to inform that:
The Company does not have any funds remaining unutilised as on 30th September 2026,
or as on date, out of the proceeds of public issue/Rights Issue/preferential issue,
qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the
past.
In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the
said Regulation / Circular.
This is for your information and records.
Thanking You.
Yours faithfully
FOR, SHREE GANESH BIOTECH (INDIA) LIMITED
Aman Patel
Wholetime Director